146 related articles for article (PubMed ID: 31684771)
1. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
[No Abstract] [Full Text] [Related]
2. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
Lee S; Kim HA; Yoon YH
Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
[TBL] [Abstract][Full Text] [Related]
3. Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.
Lim IL; Loo AVP; Subrayan V; Khang TF; See MH; Alip A; Taib NAM
Breast; 2018 Jun; 39():117-122. PubMed ID: 29660599
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
5. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
Neuville J; Yevseyenkov V
Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
[TBL] [Abstract][Full Text] [Related]
6. Retinal structural changes in patients receiving tamoxifen therapy by spectral-domain optical coherence tomography.
Bolukbasi S; Kandemir Gursel O; Cakir A; Erden B; Karatas G
Cutan Ocul Toxicol; 2020 Jun; 39(2):115-121. PubMed ID: 32100607
[No Abstract] [Full Text] [Related]
7. Macula pigment optical densitometry changes in hydroxychloroquine use.
Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
[TBL] [Abstract][Full Text] [Related]
8. Maculopathy following extended usage of Clomiphene citrate.
Tunc M
Eye (Lond); 2014 Sep; 28(9):1144-6. PubMed ID: 24858527
[No Abstract] [Full Text] [Related]
9. Influence of macular oedema on the measurement of macular pigment optical density.
Thiele S; Rauscher FG; Wiedemann P; Dawczynski J
Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):455-65. PubMed ID: 26100452
[TBL] [Abstract][Full Text] [Related]
10. Pseudocystic foveal cavitation in tamoxifen retinopathy.
Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].
Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W
Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276
[TBL] [Abstract][Full Text] [Related]
12. [Unusual symptoms for tamoxifen-associated maculopathy].
Hager T; Hoffmann S; Seitz B
Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
[TBL] [Abstract][Full Text] [Related]
13. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
Shinkai A; Saito W; Hashimoto Y; Ishida S
BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
[TBL] [Abstract][Full Text] [Related]
14. Tomographic assessment of vitreous surgery for diabetic macular edema.
Otani T; Kishi S
Am J Ophthalmol; 2000 Apr; 129(4):487-94. PubMed ID: 10764858
[TBL] [Abstract][Full Text] [Related]
15. [Tamoxifen retinopathy: a case series of clinical and functional data].
Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L
Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107
[TBL] [Abstract][Full Text] [Related]
16. Combined hamartoma of the retina and retinal pigment epithelium in 77 consecutive patients visual outcome based on macular versus extramacular tumor location.
Shields CL; Thangappan A; Hartzell K; Valente P; Pirondini C; Shields JA
Ophthalmology; 2008 Dec; 115(12):2246-2252.e3. PubMed ID: 18995912
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen retinopathy.
Kaiser-Kupfer MI; Lippman ME
Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors of Tamoxifen Retinopathy.
Kim HA; Lee S; Eah KS; Yoon YH
Ophthalmology; 2020 Apr; 127(4):555-557. PubMed ID: 31813590
[No Abstract] [Full Text] [Related]
19. Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects - A Prospective Diagnostic Study.
Bruns Y; Junker B; Boehringer D; Framme C; Pielen A
Clin Ophthalmol; 2020; 14():1011-1017. PubMed ID: 32308361
[TBL] [Abstract][Full Text] [Related]
20. [Macular diseases--application of automated static perimetry and optical coherence tomography].
Iijima H
Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):943-59. PubMed ID: 11193945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
